17 research outputs found
Multifunctional tadpole-like bimetallic nanoparticles realizes synergistic sterilization with chemical kinetics and photothermal therapy
Anti-MicroRNA-21 Oligonucleotide Loaded Spermine-Modified Acetalated Dextran Nanoparticles for B1 Receptor-Targeted Gene Therapy and Antiangiogenesis Therapy
The use of nanoparticles (NPs) to deliver small inhibiting microRNAs (miRNAs) has shown great promise for treating cancer. However, constructing a miRNA delivery system that targets brain cancers, such as glioblastoma multiforme (GBM), remains technically challenging due to the existence of the bloodâtumor barrier (BTB). In this work, a novel targeted antisense miRNAâ21 oligonucleotide (ATMOâ21) delivery system is developed for GBM treatment. Bradykinin ligand agonistâdecorated spermineâmodified acetalated dextran NPs (SpAcDex NPs) could temporarily open the BTB by activating Gâproteinâcoupled receptors that are expressed in tumor blood vessels and tumor cells, which increase transportation to and accumulation in tumor sites. ATMOâ21 achieves high loading in the SpAcDex NPs (over 90%) and undergoes gradual controlled release with the degradation of the NPs in acidic lysosomal compartments. This allows for cell apoptosis and inhibition of the expression of vascular endothelial growth factor by downregulating hypoxiaâinducible factor (HIFâ1α) protein. An in vivo orthotopic U87MG glioma model confirms that the released ATMOâ21 shows significant therapeutic efficacy in inhibiting tumor growth and angiogenesis, demonstrating that agonistâmodified SpAcDex NPs represent a promising strategy for GBM treatment combining targeted gene therapy and antiangiogenic therapy
Magnetofluorescent Carbon Quantum Dot Decorated Multiwalled Carbon Nanotubes for Dual-Modal Targeted Imaging in Chemo-Photothermal Synergistic Therapy
Magnetofluorescent
nanoparticles with diagnostic and therapeutic
functions show great promise in nanomedicine. Here, we report the
magnetofluorescent carbon nanotubes (CNTs)/doxorubicin (DOX) nanocomposites
and their functions act in synergetic chemo-photothermal synergistic
therapy (Chemo/PTT) in cancer excision. Magnetofluorescent CNTs conjugated
with a folic acid (FA-GdN@CQDs-MWCNTs) were targets for dual-modal
fluorescence (FL)/magnetic resonance (MR) imaging. Experiments in
vitro and in vivo identified FA-GdN@CQDs-MWCNTs with low toxicity,
and good biocompatibility. Moreover, FA-GdN@CQDs-MWCNTs whose release
can be fostered by pH and NIR light dual-stimuli had been proved to
be available for loading DOX. Following nuclear translocations, FA-GdN@CQDs-MWCNTs
were engineered to deliver DOX that targeted the nuclei. In vivo experiment
indicates that the Chemo/PTT, as compared with the respective single
treatment, can significantly control tumor growth. In addition, Chemo/PTT
was not shown to render any appreciable toxicity. These findings suggest
that the FA-GdN@CQDs-MWCNTs/DOX could function as a multifunctional
platform for simultaneous FL/MR imaging, PTT therapy, and drug delivery